Diagnio

📍 Dubai, United Arab Emirates🗓 Founded 2022👥 6 employees💰 Last funded Feb 2024
Home Health Care Services🌐 diagnio.com
Website LinkedIn
Diagnio is a UAE Future 100 Company, with a mission to transform womens health diagnostics into easy to use, continuous, lab-accurate at-home experience. We help women get a clear understanding of their reproductive and hormonal health, be it diagnosing fertility issues, going through post-childbirth recovery, coping with unwanted endocrinological symptoms or navigating menopause. Diagnio’s first product uses a sample of saliva to measure estrogen levels to determine the cycle phase and ovulation via special medical device and mobile application. Pre-order now at https://diagnio.com with a 20% discount 🌿 The 3 key pillars of our offering are: objective data from biosensors, algorithms for personalized analytics and actionable advice from online consultations with specialists. We have our own R&D capabilities, partnering Universities and patent-pending technology to develop our hormonal panel further.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Saudi Arabia
1
Frequently asked questions
Who invested in Diagnio?
Diagnio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Diagnio last raise funding?
The most recent investment in Diagnio recorded on gritt.io was in February 2024.
When was Diagnio founded?
Diagnio was founded in 2022.
What industry is Diagnio in?
Diagnio operates in Home Health Care Services. Find similar Home Health Care Services investors on gritt.io.
Where is Diagnio based?
Diagnio is headquartered in Dubai, United Arab Emirates.